Biotech IPO window is open, but big pharma M&As set the pace: bankers
Public markets are beginning to reopen for biotech companies after several years of subdued activity. But stronger companies are still…
ARK Genomic Revolution ETF
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. He wanted my help to build a platform on CNBC…
In the fight against cystic fibrosis, Boomer Esiason and his son Gunnar win
When NFL quarterback Boomer Esiason was about to walk onto the New York Jets' practice field in 1993, shortly after…
FDA Vaccine Director to Resign in April After Series of Controversial Decisions
The Food and Drug Administration logo before a news conference at Health and Human Services Headquarters in Washington, April 22,…
FDA Reversals on UniQure, Moderna Approvals Worry Investors
Investors are concerned about the fate of multiple experimental drugs for difficult-to-treat diseases following a series of recent rejections by…
FDA Official Discusses UniQure Gene Therapy for Huntington's Disease
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure needs to conduct another study to show that…
FDA agrees to review Moderna's flu vaccine application after denial
A researcher works in the laboratory at Moderna's headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg…
FDA chief warns that US is losing ground to China in early drug trials
Food and Drug Administration Commissioner Marty Makary warned that the United States is falling behind China in the early stages…